Insider holders · CIK 0001429560
TREVENA INC · TRVN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Carrie L. BourdowPresident and CEO | 304,500 | — | 304,500 | Feb 5, 2019 · 8:41 am EST | Form 4 |
| Maxine GowenPresident & CEO | 54,000 | 195,512 | 249,512 | Feb 5, 2019 · 4:59 pm EST | Form 4 |
| Leon O Moulder Jr.Director | 50,000 | 100,000 | 150,000 | Feb 4, 2019 · 9:01 am EST | Form 4 |
| Mark DemitrackSr VP & Chief Medical Officer | 125,000 | — | 125,000 | Dec 7, 2018 · 4:40 pm EST | Form 4 |
| Robert T YoderSr. VP, Chief Business Officer | 100,000 | — | 100,000 | Dec 10, 2018 · 5:04 pm EST | Form 4 |
| John P. HamillVP Fin,Princ Fin&Acct Officer | 80,250 | — | 80,250 | Dec 10, 2018 · 4:49 pm EST | Form 4 |
| Michael W. LarkSr. VP, Research & CSO | 74,761 | — | 74,761 | Feb 14, 2017 · 5:20 pm EST | Form 4 |
| Jonathan ViolinSVP-Scientific Affairs & IR | 10,192 | — | 10,192 | Feb 8, 2018 · 5:29 pm EST | Form 3 |
| Jason Raleigh NunnDirector | — | 4,271 | 4,271 | May 17, 2018 · 5:38 pm EDT | Form 4 |
| David SoergelSr. VP,Clinical Dev. & CMO | 1,750 | — | 1,750 | Dec 11, 2015 · 5:17 pm EST | Form 4 |
| David GeogheganSr. VP, Operations | 0 | — | 0 | Feb 8, 2018 · 5:29 pm EST | Form 3 |
| Yacoub HabibSVP, Bus Dev & Corp Planning | 0 | — | 0 | Mar 23, 2018 · 5:16 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.